The regional susceptibility of the retina to diseases has been well known by clinicians for many years. It is surprising that the implications of these observations have not spawned major research efforts to characterise the structural and functional attributes of the outer retina in different regions of a foveate retina. Without such an effort, the understanding of the disease mechanisms in retinal dystrophies will remain limited and may hamper therapeutic efforts. That outer retinal disease is responsible for over 50% of blind registration in the western world underlines the importance of these considerations.
During the last 10 years or so, there has been renewed interest in Type 2 macular telangiectasis. It has been shown that it is a disorder of neurons and glia rather than of blood vessels, as was previously thought, and it is likely that the vascular changes occur as a consequence of neuroglial disease. In addition, the research has also made interesting observations concerning the distribution of change. In early disease, both increased intra-retinal light scatter as shown by blue light reflectance, and loss of luteal pigment as shown by dual wavelength autofluorescence identify a welldefined area of abnormality centred on the fovea [1] ( Fig. 1) . As the disorder progresses, loss of photoreceptor cells and vascular telangiectasis occur temporal to the fovea and subsequently extend to occupy the area defined by blue light reflectance and dual wavelength autofluorescence but does not extend beyond it. Functional loss corresponds with loss of photoreceptors as shown by optical coherence tomography. These observations pose the question as to why this well-defined retinal region is susceptible to this disease but the remaining retina is destined to be normal, at least clinically. The explanation is likely to be related to both the metabolic attributes of this region of retina that differs from those outside the area, and the functional disturbance generated by the disorder. Concerning the former, little is known. Knowledge of the latter will depend upon identification of the genetic variants conferring risk and the metabolic consequences of the variants.
Regional affection of outer retinal diseases in human is not restricted to Type 2 macular telangiectasis and is a characteristic of many disorders. For example, in Bull's eye macular dystrophies outer retinal atrophy encircles the fovea [2] , but starts at an eccentricity that differs from one case to another, while sparing the foveola over long periods (Fig. 2) . The A2343G mitochondrial mutation causes atrophy in well-defined atrophic patches that are circumferentially orientated and circumferentially distributed around the fovea. These patches enlarge slowly but the fovea may survive for many years [3] (Fig. 3) . Similar distribution of atrophy is seen in some cases of geographic atrophy as part of age-related macular disease (Fig. 4) [4] . Central retinal degeneration with foveal sparing is also seen in some cases of Stargardt disease due to mutations in ABCA4 [5] (Fig. 5 ). The PRPH2 (RDS) 172 mutation causes atrophy centred on the fovea that does not extend beyond the optic disc [6] (Fig. 6 ). In autosomal dominant Best disease, the deposit and subsequent atrophy is characteristically limited to the fovea [7] (Fig. 7 ). All these observations illustrate the regional susceptibility of the retina to disease, and highlight the potential relevance of the metabolic attributes of different regions of the retina to the pathogenesis of hereditable macular dystrophies. There are clear physical differences between the macular and peripheral retina. Macular photoreceptor cells have long axons, and the outer segments of foveal cones resemble physically those of rods rather than peripheral cones. In the macula, Müller cells are long and subserve the needs of photoreceptor cells except at the foveolar, where they are short and exist in a 1:1 ratio with cones. Whether or not these physical attributes are associated with differences in functional attributes is unknown and indicates a major gap in knowledge. Recently, major advances have been made in the understanding of outer retinal metabolism particularly with respect to retinal energy generation [8, 9] . However, the work has been undertaken on rodents that do not possess a macula thus precluding the comparison of functional characteristics of the macula and peripheral retina. Moreover, the clinical observation of foveal sparing implies that major metabolic differences exist between foveolar and nonfoveal macula. It follows that it is important to repeat metabolic investigation of the retina in foveate animals to identify possible explanations for the regional distribution of human diseases. Furthermore, it should not be assumed that the metabolic attributes of the peripheral retina in rodents are similar to those in primates.
These observations imply the need for a major change in research priorities if the understanding of human retinal disease is to be advanced. It is frequently stated that cost precludes the widespread work on primates. However, in large primate colonies death from old age occurs on a regular basis and eyes could be made available at relatively low cost. Large colonies of marmosets exist and their availability may represent a source of eyes that is manageable financially [10] . Marmosets have a well developed macula that is similar to that in human [11] [12] [13] [14] , and are suitable for anatomical and biological studies [15, 16] . The practically of Marmosets is manifest by the many who have studied retinal connectivity with higher neural structures and intra-retinal connectivity. This contrasts with the few who have studied outer retinal metabolism.
In addition, the use of human donor eyes could be extended. This is illustrated by the use of post-mortem eyes with and without age-related disease (AMD) donated for research. It has been shown that retinal pigment epithelial mitochondria have accumulated changes that were greater in AMD eyes and in those with the high-risk CFH gene variant when compared with those without AMD and with those with the low-risk CFH variant [17, 18] . However, the changes were not greater in the macula than in the peripheral retina [19] .
It could be argued that, for cell transplantation and gene therapy as therapeutic approaches, these considerations concerning regional retinal metabolic attributes may not be important. However, if pharmacological treatment is to be initiated, knowledge of pathogenetic mechanisms of disease may be crucial for success. It may also be the case that knowledge of the metabolic attributes critical to the pathogenesis of retinal dystrophies may be important to verify the suitability of cells for transplantation and of the potential effectiveness of gene therapy. As work on primates progresses, it may allow further investigation that would shed light on the cause of retinal dystrophies other than those affecting the macula. For example, retinitis pigmentosa frequently affects the retina at 12-20 degrees of eccentricity first whatever the genetic mutation involved for which no explanation exists. This is best illustrated by disease due to mutations in the NR2E3 gene [20] (Fig. 8) . Whether or not the high density of photoreceptor cells in this region is relevant to regional affection in retinitis pigmentosa is not known.
The regional susceptibility of the retina to diseases has been well known by clinicians for many years. It is surprising that the implications of these observations have not spawned major research efforts to characterise the structural and functional attributes of the outer retina in different regions of a foveate retina. Without such an effort, the understanding of the disease mechanisms in retinal dystrophies will remain limited and may hamper therapeutic efforts. That outer retinal disease is responsible for over 50% of blind registration in the western world underlines the importance of these considerations [21] . 
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